In the past 52-week period, shares of Exact Sciences Corporation (NASDAQ:EXAS) have moved within the range of $13.05 to $63.60. On the stock’s most recent trading day, the company’s shares ended the regular session at $51.79, which is 18.57% lower than its 52-week high.
Exact Sciences Corporation (EXAS) has demonstrated a 20-day simple moving average (SMA) of -2.69%, and a 50-day SMA of -5.52%. This public company’s current market capitalization stands at $6.45 billion.Analyzing Consensus Estimates, Sales Revenue and Net Income
When considering entering a position, it is crucial to understand the average enthusiasm level expressed by Wall Street analysts for that particular stock. According to the latest data, the consensus recommendation for Exact Sciences Corporation (EXAS) is Outperform.
Publicly-traded organizations typically post revenue and earnings results that fall either above or below the average Wall Street estimate. In the most recent quarterly financial report, for the quarter ending Sep. 2017, Exact Sciences Corporation (EXAS) delivered a 11.63% surprise with its net revenue. Sales reached $0.07 billion during the three-month period, compared to the average analyst estimate of $0.07 billion.Ownership at Exact Sciences Corporation (EXAS), According to Most Recent SEC Filings
We can find critical insight by examining institutional ownership, which are reported in public companies’ most recent 13F filings. Exact Sciences Corporation (EXAS) has 0 billion shares outstanding currently, 82.40% of which belong to institutional investors. Those institutional holdings amount to $5.18 billion.
Additionally, according to the most recent 13F filing from Exact Sciences Corporation (EXAS), there were 49 new positions totaling 1,746,367 shares of the company’s stock. There were 34 sold out positions, on the other hand, totaling 2,260,913 shares.Short, Medium and Long Term Indicators
A stock’s average trade volume, as recorder over the short, medium and long terms, is helpful to analyze in order to gain a better understanding of trading activity and investor sentiment. Exact Sciences Corporation (EXAS) has had a 20-day average volume of 1,624,950 shares, with an average of 80% of short term indicators pointed at Sell.
The stock’s 50-day average volume has been 1,703,038 shares, with an average of 50% of medium term indicators pointing toward Sell. Finally, its 100-day average volume is 1,563,120 shares with 67% of long-term indicators pointing to Buy.